STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. ReFocus [Internet]. 2023 Feb. 5 [cited 2026 Sep. 12];2(1):11-9. Available from: https://refocus.uz/index.php/rf/article/view/2819